| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
28,770,000 |
| Market
Cap: |
355.88(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.37 - $41.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Biomea Fusion is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Co.'s proprietary FUSION System discovery platform is built to advance a pipeline of novel irreversible small molecule product candidates. Co.'s lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
9,100 |
| Total Buy Value |
$0 |
$0 |
$0 |
$70,936 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
125,000 |
1,100,000 |
| Total Sell Value |
$0 |
$0 |
$4,263,915 |
$33,230,447 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
11 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Erdtmann Rainer M |
President & COO |
• • • |
2021-08-18 |
4 |
B |
$10.77 |
$150,738 |
I/I |
14,000 |
204,470 |
2.64 |
-27% |
|
| Butler Thomas Andrew |
CEO |
• • • |
2021-08-18 |
4 |
B |
$10.77 |
$150,738 |
I/I |
14,000 |
204,470 |
2.64 |
-27% |
|
| Erdtmann Rainer M |
President & COO |
• • • |
2021-08-17 |
4 |
B |
$10.79 |
$151,067 |
I/I |
14,000 |
190,470 |
2.64 |
-29% |
|
| Butler Thomas Andrew |
CEO |
• • • |
2021-08-17 |
4 |
B |
$10.79 |
$151,067 |
I/I |
14,000 |
190,470 |
2.64 |
-29% |
|
| Cormorant Asset Management, Lp |
10% Owner |
– – • |
2021-04-20 |
4 |
B |
$17.00 |
$15,300,000 |
I/I |
900,000 |
3,170,872 |
1.5 |
-19% |
|
| Cormorant Asset Management, Lp |
10% Owner |
– – • |
2021-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,270,872 |
2,270,872 |
|
- |
|
| Erdtmann Rainer M |
President and COO |
• • • |
2021-04-15 |
4/A |
B |
$17.00 |
$142,800 |
I/I |
8,400 |
3,000 |
2.64 |
- |
|
| Erdtmann Rainer M |
President & COO |
• • • |
2021-04-15 |
4 |
B |
$17.00 |
$2,999,990 |
I/I |
176,470 |
176,470 |
2.64 |
- |
|
| Butler Thomas Andrew |
CEO |
• • • |
2021-04-15 |
4 |
B |
$17.00 |
$2,999,990 |
I/I |
176,470 |
176,470 |
2.64 |
- |
|
| A2a Pharmaceuticals, Inc. |
10% Owner |
– – • |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,365,342 |
|
- |
|
| Biomea Health, Llc |
10% Owner |
– – • |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,365,342 |
|
- |
|
| Butler Thomas Andrew |
CEOOfficer |
• • • |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,283,599 |
|
- |
|
| Stergiopoulos Sotirios |
Director |
– • – |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,365,342 |
|
- |
|
| Erdtmann Rainer M |
President and COOOfficer |
• • • |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,283,599 |
|
- |
|
| Ryan Sunny |
EVP of FinanceOfficer |
• – – |
2021-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,114 |
|
- |
|
40 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.92 (8.03%) 
